Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT05983679

Prevalence of Sexually Transmitted Infections (STIs) and Coinfections in the General Population

Prevalence of Sexually Transmitted Infections (STIs) and co-infections in the general population

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

HIV Infections Blood-Borne Infections Communicable Diseases Genital Diseases Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject, male or female, 18 years of age or older
  • Subject capable of understanding the purpose of the research having given their free and informed written consent
  • Subject presenting to the laboratory for a biological examination
  • Affiliated subject or beneficiary of a social security scheme

Exclusion criteria

  • Protected subject: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision

Treatment and study plan

Blood sample

Diagnostic Test

Blood sample

Primary outcomes

  1. The prevalence of each STI will be assessed by the participant's positive or negative status for each pathogen, determined by the following screening tests:

    Time frame: 3 years

    HIV testing is based on finding antibodies to HIV-1 and HIV-2 and P24 antigen of the virus;

    • Hepatitis B screening is based on HBsAg (hepatitis B surface antigen) research;
    • Herpes screening is based on testing for antibodies to Herpes Simplex virus (HSV-1 and HSV-2);
    • Papilloma virus screening is based on the HPV-HR test from a smear on the cervix;
    • Chlamydia screening is based on a nucleic acid amplification (NAAT) test;
    • Gonorrhea screening is based on the identification of the bacteria on a urine sample or secretions from the vagina or cervix;
    • Screening for trichomoniasis is based on a molecular diagnosis that involves identifying the parasite's DNA from a genital or urinary sample;
    • The detection of syphilis is based on antibody research.

Interested in participating?

Not yet recruiting

Trial opening soon.

Get Notified

Sponsors and collaborators

Lead sponsor

CerbaXpert

Other

Registry information

Official study title

Prevalence of Sexually Transmitted Infections (STIs) and Co-infections in the General Population

Acronym: PREMINF

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Aug 9, 2023
Registry last updated
Apr 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.